VNDA - Vanda Pharmaceuticals Inc
IEX Last Trade
5.28
0.060 1.136%
Share volume: 600,277
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$5.22
0.06
1.15%
Summary score
10%
Profitability
4%
Dept financing
4%
Liquidity
74%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2020 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0.63%
Return on assets
0.42%
Return on sales
1.65%
Return on invested capital
8.3%
Total debt ratio
15.83%
Debt ratio change over timeo
-0.16%
Current Ratio
5.82%
Quick Ratio
5.8%
Cash Position Ratio
5.23%
Short-term ratios 30-Jun-2023 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-0.5%
Return on assets
-1.25%
Return on sales
-17.67%
Return on invested capital
-2.12%
Total debt ratio
16.17%
Debt ratio change over timeo
0.19%
Current Ratio
5.16%
Quick Ratio
5.15%
Cash Position Ratio
4.64%
Last quarter ratios 30-Jun-2024
The data are presented for the financials results of the last quarter.
Return on equity
-0.83%
Return on assets
-1.56%
Return on sales
-20.1%
Return on invested capital
-3.82%
Total debt ratio
16.71%
Debt ratio change over time
-9.9%
Current Ratio
4.68%
Quick Ratio
4.67%
Cash Position Ratio
4.13%
Performance ratios (change over 4 years) 30-Jun-2020 - 30-Jun-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-91.7%
Return on assets
-96.35%
Return on sales
-93.05%
Return on invested capital
-16.43%
Total debt ratio
-15.92%
Debt ratio change over time
-0.16%
Current Ratio
44.87%
Quick Ratio
44.82%
Cash Position Ratio
41.42%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | VNDA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 0.63% | 15.05% | 35.64% | 7.13% |
| Return on assets | 0.42% | 2.88% | 3.13% | 5.53% |
| Return on sales | 1.65% | 29.62% | 32.25% | 40.49% |
| Return on invested capital | 8.3% | 2.57% | 5.37% | 18.48% |
| Profitability | 15% | 45% | 66% | 80% |
| Total debt ratio | 15.83% | 90.48% | 91% | 25.78% |
| Debt ratio change over time | -0.16% | 326.95% | -8.44% | 1.18% |
| Dept financing | 4% | 50% | 25% | 7% |
| Current Ratio | 5.16% | 0.92% | 1.98% | 5.39% |
| Quick Ratio | 5.15% | 0.81% | 1.56% | 4.63% |
| Cash Position Ratio | 4.64% | 0.39% | 1.05% | 2.91% |
| Liquididy | 75% | 9% | 19% | 47% |
| Short-term ratios | VNDA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -0.5% | 13.14% | 10.88% | 4.07% |
| Return on assets | -1.25% | 2.1% | 1.54% | 3.03% |
| Return on sales | -17.67% | 21.74% | 18.43% | 30.26% |
| Return on invested capital | -2.12% | 1.95% | 2.74% | 9.55% |
| Profitability | 0% | 65% | 56% | 83% |
| Total debt ratio | 16.17% | 92.68% | 93.24% | 21.84% |
| Debt ratio change over time | 0.19% | 51.04% | -101.54% | 1.43% |
| Dept financing | 4% | 50% | 25% | 7% |
| Current Ratio | 5.16% | 0.92% | 1.98% | 5.39% |
| Quick Ratio | 5.15% | 0.81% | 1.56% | 4.63% |
| Cash Position Ratio | 4.64% | 0.39% | 1.05% | 2.91% |
| Liquididy | 74% | 10% | 22% | 63% |